|
MechanismHER2 antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Syntarga BV
0 Patents (Medical) associated with Syntarga BV
100 Deals associated with Syntarga BV
100 Translational Medicine associated with Syntarga BV